详情页 - 广东省中医院知识库

当前位置：首页 > 详情页

Sanqi Oral Solution Mitigates Proteinuria in Rat Passive Heymann Nephritis and Blocks Podocyte Apoptosis via Nrf2/HO-1 Pathway (vol 12, 727874, 2021)

11| 认领 | 导出 | 链接全文 |

文献详情

资源类型：

WOS体系：

Pubmed体系：

收录情况： ◇ SCIE

作者：

机构： [1]Guangzhou Univ Chinese Med, State Key Lab Dampness Syndrome Chinese Med, Affiliated Hosp 2, Guangzhou, Peoples R China [2]Guangdong Prov Hosp Chinese Med, Dept Nephrol, Guangzhou, Peoples R China [3]Guangdong Prov Key Lab Chinese Med Prevent & Treat, Guangzhou, Peoples R China [4]Guangdong Prov Acad Chinese Med Sci, Guangzhou, Peoples R China [5]Guangzhou Key Lab Chiral Res Act Components Tradit, Guangzhou, Peoples R China

出处：

DOI：

ISSN：

关键词： Sanqi oral solution passive Heymann nephritis podocyte apoptosis proteinuria Nrf2 HO-1 signaling pathway

摘要：

语种：

WOS：

PubmedID：

中科院(CAS)分区：

出版当年[2021]版：

大类 | 2 区

医学

小类 | 2 区药学

最新[2025]版：

大类 | 3 区医学

小类 | 3 区药学

JCR分区：

出版当年[2020]版：

Q1 PHARMACOLOGY & PHARMACY

最新[2023]版：

Q1 PHARMACOLOGY & PHARMACY

影响因子： 4.4 最新[2023版] 5 最新五年平均 5.811 出版当年[2020版] 6.006 出版当年五年平均 4.225 出版前一年[2019版] 5.988 出版后一年[2021版]

第一作者：

第一作者机构： [1]Guangzhou Univ Chinese Med, State Key Lab Dampness Syndrome Chinese Med, Affiliated Hosp 2, Guangzhou, Peoples R China [2]Guangdong Prov Hosp Chinese Med, Dept Nephrol, Guangzhou, Peoples R China [3]Guangdong Prov Key Lab Chinese Med Prevent & Treat, Guangzhou, Peoples R China [4]Guangdong Prov Acad Chinese Med Sci, Guangzhou, Peoples R China

通讯作者：

通讯机构： [1]Guangzhou Univ Chinese Med, State Key Lab Dampness Syndrome Chinese Med, Affiliated Hosp 2, Guangzhou, Peoples R China [2]Guangdong Prov Hosp Chinese Med, Dept Nephrol, Guangzhou, Peoples R China [3]Guangdong Prov Key Lab Chinese Med Prevent & Treat, Guangzhou, Peoples R China [4]Guangdong Prov Acad Chinese Med Sci, Guangzhou, Peoples R China [5]Guangzhou Key Lab Chiral Res Act Components Tradit, Guangzhou, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

相关文献

[1]Sanqi Oral Solution Mitigates Proteinuria in Rat Passive Heymann Nephritis and Blocks Podocyte Apoptosis via Nrf2/HO-1 Pathway. [2]Corrigendum: Sanqi Oral Solution Mitigates Proteinuria in Rat Passive Heymann Nephritis and Blocks Podocyte Apoptosis via Nrf2/HO-1 Pathway. [3]Sanqi oral solution ameliorates renal damage and restores podocyte injury in experimental membranous nephropathy via suppression of NFκB [4]Levistilide a Induces Ferroptosis by Activating the Nrf2/HO-1 Signaling Pathway in Breast Cancer Cells [5]Forsythiaside A Exhibits Anti-inflammatory Effects in LPS-Stimulated BV2 Microglia Cells Through Activation of Nrf2/HO-1 Signaling Pathway. [6]Icariin inhibits osteoblast ferroptosis via Nrf2/HO-1 signaling and enhances healing of osteoporotic fractures [7]Metabonomic Analysis of the Therapeutic Effects of Chinese Medicine Sanqi Oral Solution on Rats With Exhaustive Exercise [8]Sanqi Oral Solution Ameliorates Renal Ischemia/Reperfusion Injury via Reducing Apoptosis and Enhancing Autophagy: Involvement of ERK/mTOR Pathways [9]Platycodon D protects human nasal epithelial cells from pyroptosis through the Nrf2/HO-1/ROS signaling cascade in chronic rhinosinusitis [10]Metformin suppresses oxidative stress induced by high glucose via activation of the Nrf2/HO-1 signaling pathway in type 2 diabetic osteoporosis